Background: Various prognostic factors in assisted reproduc tion procedures have been described and analyzed which includes woman's age, cause of infertility, ovarian response and uterine receptivity, the semen quality, and the body mass index (BMI). Optimal BMI is required for an optimal response. There is controversy among various reports, which is partly caused by the varying focus of investigators and differences in study designs, which led us to examine the relationship between BMI, in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) outcome in our unit.
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[body mass index (BMI) < 18.5 kg/m 2 ], as well as overweight (BMI ≥ 25 kg/m 2 ) and obesity (BMI ≥ 30 kg/m 2 ) are asso ciated with an increased risk of anovulatory infertility.
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Reduced fecundity of underweight and overweight women is probably related to multiple endocrine and metabolic alte rations, which include effects on steroid metabolism and altered secretion and action of insulin and other hormones, such as leptin, resistin, ghrelin or adiponectin.
These alterations can affect follicle growth, embryo de velopment and implantation 46 and it is therefore of concern that being underweight or overweight may interfere with treatment of infertility with IVF and ICSI. Recently, a debate is started in literature whether or not restricting the access to fertility treatment on the ground of female BMI.
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In assisted reproduction, however, there are conflicting reports on the effect of obesity on oocyte quality, embryo development, lower number of mature oocytes, lower implantation and pregnancy rates. 1115 Endometrium also seems to have a negative impact on reproductive outcome in studies based on oocyte donation model.
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Clinical observations on the effects of body weight during IVF and ICSI are conflicting changes in BMI has serious impact on the various aspects of health in particular the reproductive function of women. 1922 There is contro versy among various reports, which is partly caused by the varying focus of investigators and differences in study designs, led us to examine the relationship between BMI and IVF/ICSI outcome in our unit.
MATERIALS And METHOdS

Study design
It is a prospective study over a period of 1 year in the age group 25 to 35 years (with 500 females subjects) attending the IVF clinic was conducted at a tertiary infertility center in Bangalore, India between November 2010 and October 2011. Approval was obtained from the Institutional Ethics Committee (IEC). An informed consent was taken from all patients.
Various inclusion and exclusion criteria were taken so as to avoid confounding variables as much as possible so as to get comparable results.
The patients had their BMI recorded at the initial consul tation before starting the treatment cycle. Patients with good ovarian reserves were stimulated by long against downregulation protocol for ovarian stimulation while women with poor ovarian reserves were stimulated by antagonist protocol. (Details of both the protocols are given vide infra).
Ovarian stimulation was achieved by human menopausal gonadotropin (Menopur, Ferring). As a rule, the starting daily FSH dose was 150 IU, Gonal F (Serono, Italy) or Recagon (Organon) with exception of women older than 35 years who received 225 IU and women with polycystic ovaries who received 75 to 150 IU.
The history and investigation reports were entered in a specially prepared performa. All patients undergoing con ventional IVFET or ICSI were stimulated in accordance with the appropriate protocol decided for them and the treatment cycle was monitored using transvaginal ultrasound scans (TVS) and serum estradiol (E2), progesterone (P) and luteinising hormone (LH) levels, wherever required. Injec tion uhCG, 5000IU IM (Ovutrig HP, VHB Life Sciences, Mumbai, India, Profasi, Serono or Pregnyl, Organon) or recombinant hCG 250 mcg (Ovidrel, Serono, Inc.) used in some cases (poor responders, those at high risk of OHSS) was administered when the average diameter of lead follicle becomes more than 18 mm and at least two follicles become more than 16 mm in diameter. Oocytes were retrieved 34 to 36 hours after u hCG injection, by transvaginal ultrasound guided aspiration.
Standard laboratory protocols were followed, inclu ding ICSI, laser assisted hatching (LAH) for cleavage stage embryos and extended culture for blastocyst transfer, as clinically appropriate.
dISCuSSIOn
In our study, as per age distribution, 54.6% (273/500) were in age group > 30 years and 45.4% (227/500) were < 30 years age. Group A is underweight which comprised of 2% (10) patients, 41.6% (208) in group B (Normal BMI), 42.6% (213) in group C (overweight) and 13.8% (69) in group D (obese). Mean duration of infertility was 5.27 ± 2.49 years in group B and in group C, it was 5.63 ± 2.54 years (Fig. 1) . Among the causes of infertility in all patients, most common was male factor in form of oligospermia, severe oligoasthenozoospermia, necrospermia, asthenozoospermia, azoospermia or sexual dysfunction in 60% (6) in group A, 58.7% (122) in group B, 62.9% (134) in group C and 65.2% (45) in group D followed by the tubal factor (20%), unex plained infertility (15%), ovulatory dysfunction and mixed causes in remaining patients (Table 1) .
A number of frozen embryos were more in group B and C as compared to A and D though not statistically significant (p = 0.849). Endometrial thickness was 8 to 10 mm in 98 (47.1%) in group B, 106 (49.8%) in group C as compared to 4 (40%) and 32 (46.4%) in groups A and D with p = 0.988 (statistically non significant). Day 2/3 embryo transfer was done in 62% of patients and in remaining blastocysts were transferred in our clinic (p = 0.008).
Dosage of gonadotropins was high in overweight and obese group such that 41 to 60 ampules were used in 23% in group C compared to 14% in group B ( Table 2) .
The primary and secondary outcomes of our study are depicted in Table 3 . Days of stimulation were more in group C (11.43 ± 1.49 and group D (11.67 ± 1.79) with p = 0.037.
Dosage of gonadotropins was more in overweight and obese patients (p = 0.003) compared to normal BMI and underweight groups.
A number of dominant follicles, number of mature (M2, Metaphase 2) oocytes, number of grade A (good quality) embryos formed and frozen were more in normal weight and overweight patients (groups B and C) as compared to extremes of BMI variations (underweight and obese) though ijifm not statistically significant. Mean number (2.46 ± 0.68) of embryos transferred were comparable in four groups with p = 0.289. Ninety percent of embryo transfers done were easy. Difficult embryos transfers were more in group C (8%) and group D (13%) compared to group A (none, 0%) and group B (1.4%).
Embryo transfer was cancelled in 9 (4.2%) patients in group and 4 (5.8%) in group D as compared to 2.3% in group B and none in group A (p = 0.045) (Fig. 2) .
Oocyte retrieval rate was high in group B (91.57 ± 17.55) and group C (106.29 ± 17.89) as compared to group A and D. Fertilization rate was comparable. Cleavage rate was high in groups B, C and D as compared to group A (p = 0.040). Implantation rate was almost similar in all four groups (16-17%) with p = 0.621. Pregnancy rate was 38% in group C (maximum) followed by 36% in group B, 31% in group D and 30% in group A (p = 0.828), so it was comparatively statistically nonsignificant.
A number of miscarriages were maximum in overweight and obese patients but comparable to normal BMI group with p = 0.630 (Fig. 3) .
In our study, out of 500 patients recruited, 171 were pregnant so overall pregnancy rate was 34% (171/500) with clinical pregnancy rate of 31% and 28% in overweight and normal BMI patients as compared to 17% and 20% in obese and underweight patients in comparable age group (p = 0.163) ( Table 4 and Fig. 4) .
While live birth rate was upto 26% in group C and D as compared to 20% and 24% in groups A and B (p = 0.929).
Changes in BMI have serious impact on the various aspects of health in particular the reproductive function of women. 23 The reduced fecundity of underweight and over weight women is probably related to multiple alterations in their metabolic and endocrine functions. Previous studies have suggested that women with extremes of BMI had lower numbers of oocytes, 24 lower fertilisation rate 25 and lower implantation rate 26, 27 and it is therefore of concern that being underweight or overweight may interfere with treatment of infertility with IVF and ICSI. In overweight or obese compared with normal weight women, increased FSH requirement during ovarian stimulation, frequent cycle cancellations, low pregnancy rate and higher miscarriage rate have been observed.
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In summary, this study suggests that obesity is associ ated with lower clinical pregnancy and live birth rate and the need for higher and longer period of FSH stimulation due to impaired ovarian response but underweight was not related to an impaired outcome.
STREnGTH Of STudy
The study has some significant strength. First of all, the major strength was its prospective nature. In the litera ture, most of the data about this topic have been based on retrospective studies or pooled data, thus allowing potential for observer bias.
Another advantage was, this study included only first assisted reproductive techniques (ART) cycle. There are many studies including more than one cycle of the same participants. In this situation, undiagnosed bad prognostic factors of an individual may cumulatively affect on results.
Lastly, we calculated BMI of the participants at the initiation of ovarian stimulation.
COnCLuSIOn
Body mass index has a role in counselling couples before initiation of ART.
Optimal BMI should be a pre-requisite before recruiting the patients for the controlled ovarian stimulation (COS). Obese patients should be strongly encouraged to loose weight before starting ART.
Obesity is associated with reduced pregnancy rates and increased requirement gonadotropin for ovulation induction.
Obesity is associated with an increased risk of early pregnancy loss occurring before 6 weeks gestation.
Implantation rate, pregnancy rate and miscarriage rate was comparable but live births are high in normal weight and overweight as compared to extremes of BMI due to Though, it appears appropriate to recommend weight loss prior to IVF in patients especially in young patients while in older patients, a more immediate and aggressive approach to ART may be warranted.
